Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31.3M
-
Number of holders
-
237
-
Total 13F shares, excl. options
-
36.1M
-
Shares change
-
+989K
-
Total reported value, excl. options
-
$3.2B
-
Value change
-
+$90.5M
-
Put/Call ratio
-
0.95
-
Number of buys
-
116
-
Number of sells
-
-115
-
Price
-
$88.64
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2022
285 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2022.
CONMED Corp - Common Stock (CNMD) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.1M shares
.
Largest 10 shareholders include BlackRock Inc. (4.92M shares), VANGUARD GROUP INC (3.42M shares), EARNEST PARTNERS LLC (2.4M shares), Capital Research Global Investors (2.19M shares), Champlain Investment Partners, LLC (1.28M shares), AMERIPRISE FINANCIAL INC (1.25M shares), STATE STREET CORP (1.13M shares), BANK OF AMERICA CORP /DE/ (999K shares), JPMORGAN CHASE & CO (914K shares), and LOOMIS SAYLES & CO L P (755K shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.